Stimulation of muscle contraction of the hip muscles for the prevention of bedsores in patients admitted to the IC
- Conditions
- Pressure ulcerL00-L99
- Registration Number
- RBR-8nt9m4
- Lead Sponsor
- Pontifícia Universidade Católica do Rio Grande do Sul
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Participants hospitalized at the general intensive care unit I and II of the hospital são lucas of the pontifical catholic university of rio grande do sul; 18 years of age or over; hospitalization in the intensive care unit not exceeding 48 hours; without presence of pressure ulcer in the posterior region of the pelvis; agree to participate in the study and sign the informed consent form; authorization for study participation and signing of informed consent by those responsible for the participants who are sedated and or intubated and unable to sign the term.
Pregnant women; use of a pacemaker implant or defibrillator; preexisting neuromuscular disease such as duchennes disease; myasthenia gravis; guillain barré syndrome; brain death; spinal cord injury; body mass index greater than or equal to 35 kilograms per square meter; rhabdomyolysis; injury to the skin at the electrode application site; against medical indication specified by the doctor in charge of the participant.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The expected outcome is the incidence rate of 20% of pressure ulcer (PU) in the experimental group and 40% PU incidence rate in the control group, as determined by recording the daily skin inspection by two independent evaluators to find out the appearance of PU from any stage in the posterior pelvic region.
- Secondary Outcome Measures
Name Time Method The presentation of the expected outcome in participants receiving the neuromuscular electrostimulation (NMES) protocol is the maintenance or increase of the bilateral maximal gluteal muscle diameter, determined by measuring the bilateral maximal gluteal muscle diameter by means of ultrasound (US) in the experimental group on the first day before the NMES application and on the seventh day after NMES, and then successively every seven days.<br>;The presentation of the expected outcome in participants receiving NMES protocol is the presence of homogeneity patterns of the epidermis, dermis and subcutaneous tissue of the bilateral gluteus maximus without presence of fluid or edema, determined by the measurement of the bilateral gluteus maximus through US in the experimental group on the first day before the NMES application and on the seventh day after NMES, and then successively every seven days.<br>